Preimplantation Genetics Diagnosis

Preimplantation genetic diagnosis (PGD) is called as embryo screening. It is a branch of genetics that involves genetic testing of embryos through in vitro fertilization (IVF).

PGD eliminates risk of selective pregnancy termination for couples who are at substantial risk of transferring serious genetic, chromosomal, or hereditary disorders, including  spinal muscular atrophy and cystic fibrosis.

PGD provides effective solution for healthy embryos free from genetic, hereditary, and chromosomal disorders. It is an evolving technique in modern genetic study.  In addition, increase in prevalence of hereditary, chromosomal, and genetic disorders every year that include triploidy, thalassemia, and Duchenne muscular dystrophy (DMD)requires PGD for the diagnosis of mutational changes. Moreover, increase in usage of PGD techniques in selecting human leukocyte antigen (HLA) profile to match existing sibling with disease and sex balancing in family spurred the growth of PGD market. Furthermore, growth in infertility rate and increase in awareness regarding PGD technique boost the growth of the market.